SG11201809177UA - Composition for use in the prophylaxis of allergic disease - Google Patents

Composition for use in the prophylaxis of allergic disease

Info

Publication number
SG11201809177UA
SG11201809177UA SG11201809177UA SG11201809177UA SG11201809177UA SG 11201809177U A SG11201809177U A SG 11201809177UA SG 11201809177U A SG11201809177U A SG 11201809177UA SG 11201809177U A SG11201809177U A SG 11201809177UA SG 11201809177U A SG11201809177U A SG 11201809177UA
Authority
SG
Singapore
Prior art keywords
international
rule
dgla
applicant
prophylaxis
Prior art date
Application number
SG11201809177UA
Inventor
Erik Eckhardt
Chiara Nembrini
Laureline Jourdain
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of SG11201809177UA publication Critical patent/SG11201809177UA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/14Decongestants or antiallergics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Abstract

INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 07 December 2017 (07.12.2017) WIP0 I PCT omit Oil DID Immo oimIE (10) International Publication Number WO 2017/207124 Al (51) International Patent Classification: A61K 31/202 (2006.01) A61P 27/14 (2006.01) (21) International Application Number: Published: — with international search report (Art. 21(3)) PCT/EP2017/055680 (22) International Filing Date: 10 March 2017 (10.03.2017) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 16172431.5 01 June 2016 (01.06.2016) EP (71) Applicant: NESTEC S.A. [CH/CH]; Avenue Nestle 55, 1800 VEVEY (CH). (72) Inventors: ECKHARDT, Erik; 34, rue Ernest Zegut, 01170 Gex (FR). NEMBRINI, Chiara; 34, Route de Palezieux, 1610 ORON-LA-VILLE (CH). JOURDAIN, Laureline; 1717 North Verdugo Road, Apt 284, CA, Glen- dale, California 91208 (US). (74) Agent: NAUDE, Dawn; Nestle Research Center, Vers- chez-les-Blanc, 1000 Lausanne 26 (CH). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Declarations under Rule 4.17: 1-1 as to applicant's entitlement to apply for and be granted a • patent (Rule 4.170) as to the applicant's entitlement to claim the priority of the 71' • earlier application (Rule 4.17(iii)) 11 of inventorship (Rule 4.17(iv)) O N (54) Title: COMPOSITION FOR USE IN THE PROPHYLAXIS OF ALLERGIC DISEASE 0 (57) : Dihomo-gamma-linolenic acid (DGLA) or a composition comprising DGLA for use in the prophylaxis of allergic disease \" in the offspring of mammalian subject wherein said DGLA is administered to said subject pre-pregnancy and/or during pregnancy and/ 0 or during lactation.
SG11201809177UA 2016-06-01 2017-03-10 Composition for use in the prophylaxis of allergic disease SG11201809177UA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16172431 2016-06-01
PCT/EP2017/055680 WO2017207124A1 (en) 2016-06-01 2017-03-10 Composition for use in the prophylaxis of allergic disease

Publications (1)

Publication Number Publication Date
SG11201809177UA true SG11201809177UA (en) 2018-12-28

Family

ID=56108531

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201809177UA SG11201809177UA (en) 2016-06-01 2017-03-10 Composition for use in the prophylaxis of allergic disease

Country Status (12)

Country Link
EP (1) EP3463332B1 (en)
CN (1) CN109152759A (en)
AR (1) AR107869A1 (en)
BR (1) BR112018073060A2 (en)
CA (1) CA3024191A1 (en)
ES (1) ES2877810T3 (en)
MX (1) MX2018014140A (en)
PH (1) PH12018502252A1 (en)
PT (1) PT3463332T (en)
SG (1) SG11201809177UA (en)
TW (1) TWI803459B (en)
WO (1) WO2017207124A1 (en)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5591446A (en) * 1989-04-04 1997-01-07 Beiersdorf, A.G. Methods and agents for the prophylaxis of atopy
GB9217780D0 (en) * 1992-08-21 1992-10-07 Efamol Holdings Fatty acid treatment
GB9217781D0 (en) * 1992-08-21 1992-10-07 Efamol Holdings Fatty acid treatment
CA2119000A1 (en) * 1993-03-19 1994-09-20 David Frederick Horrobin Formulation for use in smokers
EP0711503A3 (en) * 1994-11-14 1997-11-26 Scotia Holdings Plc Milk fortified with GLA and/or DGLA
GB9510636D0 (en) * 1995-05-25 1995-07-19 Scotia Holdings Plc Fatty acid treatment
US20040076695A1 (en) * 2002-07-08 2004-04-22 Advanced Vision Research EPA and DHA enriched omega-3 supplement for the treatment of dry eye, meibomianitis and xerostomia
JP5546087B2 (en) * 2005-02-14 2014-07-09 サントリーホールディングス株式会社 Oral treatment or prevention agent for skin diseases

Also Published As

Publication number Publication date
EP3463332B1 (en) 2021-04-21
AR107869A1 (en) 2018-06-13
MX2018014140A (en) 2019-02-25
ES2877810T3 (en) 2021-11-17
CA3024191A1 (en) 2017-12-07
TWI803459B (en) 2023-06-01
PT3463332T (en) 2021-06-30
WO2017207124A1 (en) 2017-12-07
CN109152759A (en) 2019-01-04
BR112018073060A2 (en) 2019-04-09
TW201742624A (en) 2017-12-16
EP3463332A1 (en) 2019-04-10
PH12018502252A1 (en) 2019-08-19

Similar Documents

Publication Publication Date Title
SG11201909963YA (en) Methods for treating dravet syndrome
SG11201809344QA (en) Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)-pyridin-3-yl)methoxy)benzaldehyde
SG11201909960UA (en) Methods for improving memory and cognition and for treating memory and cognitive disorders
SG11201909022PA (en) ANTI-N3pGlu AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF
SG11201407580YA (en) Composition comprising two antibodies engineered to have reduced and increased effector function
SG11201907032RA (en) Amino pyrimidine compounds useful as ssao inhibitors
SG11201810420YA (en) Antibodies to alpha-synuclein and uses thereof
SG11201407837WA (en) Beta-hairpin peptidomimetics
SG11201810371XA (en) ANTI-N3pGlu AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF
SG11201906436VA (en) Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same
SG11201907356SA (en) Piperidine-substituted mnk inhibitors and methods related thereto
SG11201901558VA (en) Pth compounds with low peak-to-trough ratios
SG11201805001UA (en) Method of treating influenza a
SG11201402986RA (en) Kinase inhibitors
SG11201807597UA (en) Methods of treating depression using orexin-2 receptor antagonists
SG11201807255YA (en) Treatment of autoimmune diseases with combinations of rxr agonists and thyroid hormones
SG11201901673SA (en) Imidazole derivatives and their use in the treatment of autoimmune or inflammatory diseases or cancers
SG11201806544XA (en) Compounds and methods of treating rna-mediated diseases
SG11201804587QA (en) Isoindole compounds
SG11201806424TA (en) Therapeutic compounds
SG11201408171SA (en) Fbxo3 inhibitors
SG11201908065YA (en) Deuterated imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer
SG11201806127XA (en) Pharmaceutical or nutritional combination comprising beta-hydroxy-betamethylbutyrate
SG11201810801QA (en) Brain delivery protein
SG11201901689YA (en) Compounds for treating diseases associated with a mitochondrial dysfonction